| Primary | RUST Score | The RUST scale (Radiographic Union Score for Tibial fractures; RUST) was developed in 2010 as a measure of tibial fracture healing and has been validated in the NF1 population. This was used as the primary outcome measure in this trial. The score is based on radiographic evaluation of the bone cortex based on AP (anterior-posterior) and lateral xrays. Four cortices of tibial bone seen in these views are each given a score of 1 to 3, with 1 representing no healing, 2 representing some callus present, and 3 representing healing of the bone cortex. The 4 scores are totaled, to give a total score range of 4 to 12. For the purpose of this study, a total RUST score of 9 to 12, with at least 2 evaluable cortices having a score of 3, is considered to be healed. Scores of 5 to 8 are considered to represent partial healing, and a score of 4 is considered to be no healing. | The population consisted of 2 evaluable participants. Three (3) participants withdrew for various reasons (see participant flow). The study was closed for further enrollment due to poor recruitment. The study was closed after the last participant completed study procedures. | Posted | | Median | Full Range | score on a scale | | 12 mos post surgery. The score at 12 mos post surgery will be used to determine success of healing and is the score reported. | | | | ID | Title | Description |
|---|
| OG000 | INFUSE Bone Graft (BMP-2) | Standard surgery plus BMP-2 | | OG001 | Control Group | Standard surgery without BMP-2 |
| | | Title | Denominators | Categories |
|---|
| | |
| |
| Secondary | Average Time to Healing in Months | Time to healing is determined by RUST scores calculated at 3 month intervals after surgery. The first time point at which a score of 9 to 12 is achieved on the RUST Scale will be considered the time to complete healing. One time point is reported which is the time point of first healing. | The population consisted of 2 evaluable participants. Three (3) participants withdrew for various reasons (see participant flow). The study was closed for further enrollment due to poor recruitment. The study was closed after the last participant completed study procedures. | Posted | | Median | Full Range | months | | Baseline through 12 months post-surgery. | | | | ID | Title | Description |
|---|
| OG000 | INFUSE Bone Graft (BMP-2) | Children with NF1 and tibial pseudarthrosis who require surgery will have the INFUSE bone graft added to their surgical protocol. After a standard surgical approach of resection of abnormal pseudarthrotic tissue, placement of a rigid intramedullary rod (of the surgeon's choice) and placement of autogenous bone graft from the iliac crest; in addition, the INFUSE bone graft in the form of a collagen sponge will be wrapped around the tibia during the surgical process. INFUSE Bone Graft (BMP-2): The INFUSE bone graft, containing BMP-2 on a collagen sponge, will be wrapped around the tibia during the surgical process. | | OG001 | Control Group | Children with NF1 and tibial pseudarthrosis who require surgery will receive the standard surgical protocol only. This includes resection of abnormal pseudarthrotic tissue, placement of a rigid intramedullary rod (of the surgeon's choice) and placement of autogenous bone graft from the iliac crest. Control Group: The control group will receive the standard surgical protocol, without addition of the INFUSE device. |
|
| Secondary | Refracture Rate | Numbers of patients with refracture within 1 year after surgery. | The population consisted of 2 evaluable participants. Three (3) participants withdrew for various reasons (see participant flow). The study was closed for further enrollment due to poor recruitment. The study was closed after the last participant completed study procedures. | Posted | | Count of Participants | | Participants | | 12 months post-surgery | | | | ID | Title | Description |
|---|
| OG000 | INFUSE Bone Graft (BMP-2) | Children with NF1 and tibial pseudarthrosis who require surgery will have the INFUSE bone graft added to their surgical protocol. After a standard surgical approach of resection of abnormal pseudarthrotic tissue, placement of a rigid intramedullary rod (of the surgeon's choice) and placement of autogenous bone graft from the iliac crest; in addition, the INFUSE bone graft in the form of a collagen sponge will be wrapped around the tibia during the surgical process. INFUSE Bone Graft (BMP-2): The INFUSE bone graft, containing BMP-2 on a collagen sponge, will be wrapped around the tibia during the surgical process. | | OG001 | Control Group | Children with NF1 and tibial pseudarthrosis who require surgery will receive the standard surgical protocol only. This includes resection of abnormal pseudarthrotic tissue, placement of a rigid intramedullary rod (of the surgeon's choice) and placement of autogenous bone graft from the iliac crest. Control Group: The control group will receive the standard surgical protocol, without addition of the INFUSE device. |
|
| Secondary | Long-term Refracture | Numbers of patients with refracture over long-term follow up of up to 10 years. | The population consisted of 2 evaluable participants. Three (3) participants withdrew for various reasons (see participant flow). The study was closed for further enrollment due to poor recruitment. The study was closed after the last participant completed study procedures. | Posted | | Count of Participants | | Participants | | annually, up to 10 years post-surgery | | | | ID | Title | Description |
|---|
| OG000 | INFUSE Bone Graft (BMP-2) | Children with NF1 and tibial pseudarthrosis who require surgery will have the INFUSE bone graft added to their surgical protocol. After a standard surgical approach of resection of abnormal pseudarthrotic tissue, placement of a rigid intramedullary rod (of the surgeon's choice) and placement of autogenous bone graft from the iliac crest; in addition, the INFUSE bone graft in the form of a collagen sponge will be wrapped around the tibia during the surgical process. INFUSE Bone Graft (BMP-2): The INFUSE bone graft, containing BMP-2 on a collagen sponge, will be wrapped around the tibia during the surgical process. | | OG001 | Control Group | Children with NF1 and tibial pseudarthrosis who require surgery will receive the standard surgical protocol only. This includes resection of abnormal pseudarthrotic tissue, placement of a rigid intramedullary rod (of the surgeon's choice) and placement of autogenous bone graft from the iliac crest. Control Group: The control group will receive the standard surgical protocol, without addition of the INFUSE device. |
|
| Secondary | Ten Meter Timed Walk | Time (seconds) to perform the Ten Meter Timed Walk. Assessed at 6 and 12 months after surgery. Both 6 month and 12 month reported. | The population consisted of 2 evaluable participants. Three (3) participants withdrew for various reasons (see participant flow). The study was closed for further enrollment due to poor recruitment. The study was closed after the last participant completed study procedures. | Posted | | Median | Full Range | seconds | | Assessed at 6 and 12 months after surgery. Month 12 reported. | | | | ID | Title | Description |
|---|
| OG000 | INFUSE Bone Graft (BMP-2) | Standard surgery plus BMP-2 | | OG001 | Control Group | Standard surgery without BMP-2 |
| |
| Secondary | Pain Intensity | Pain Intensity was measured using the Faces Pain Scale-Revised (FPS-R) for patients aged 4 years and older. This is a self-report pain scale, where children chose one of 6 faces to indicate their current pain. Scores range from 0 to 10, with 0 representing no pain (happy face) and 10 representing the most pain. | Participants were all too young to report on this scale (younger than age 4 years). No results are reported. | Posted | | | | | | measured at post-op visits at 6 weeks, 3 mos, 6 mos, and 12 mos after surgery | | | | ID | Title | Description |
|---|
| OG000 | INFUSE Bone Graft (BMP-2) | Children with NF1 and tibial pseudarthrosis who require surgery will have the INFUSE bone graft added to their surgical protocol. After a standard surgical approach of resection of abnormal pseudarthrotic tissue, placement of a rigid intramedullary rod (of the surgeon's choice) and placement of autogenous bone graft from the iliac crest; in addition, the INFUSE bone graft in the form of a collagen sponge will be wrapped around the tibia during the surgical process. INFUSE Bone Graft (BMP-2): The INFUSE bone graft, containing BMP-2 on a collagen sponge, will be wrapped around the tibia during the surgical process. | | OG001 | Control Group | Children with NF1 and tibial pseudarthrosis who require surgery will receive the standard surgical protocol only. This includes resection of abnormal pseudarthrotic tissue, placement of a rigid intramedullary rod (of the surgeon's choice) and placement of autogenous bone graft from the iliac crest. Control Group: The control group will receive the standard surgical protocol, without addition of the INFUSE device. |
|
| Secondary | Quality of Life Score - The Upper Extremity and Physical Function Core Scale | Quality of Life (QOL) was measured during the study using the Pediatric Outcome Data Collection Instrument (PODCI), a validated scale developed by the American Academy of Orthopaedic Surgeons to measure outcomes in orthopedic interventions. The Parent-report form, which was used for this study, consists of 86 Likert-format questions, covering 5 domains (Upper extremity and physical function; transfer and basic mobility; sports/physical functioning; pain/comfort; and happiness scales). In addition, a Global Functioning Scale is computed. Scores for each subscale range from 0 to 100, with lower scores representing better quality of life. | The population consisted of 2 evaluable participants. Three (3) participants withdrew for various reasons (see participant flow). The study was closed for further enrollment due to poor recruitment. The study was closed after the last participant completed study procedures. | Posted | | Median | Full Range | score on a scale | | Assessed at 6 and 12 months after surgery. Month 12 reported. | | | | ID | Title | Description |
|---|
| OG000 | INFUSE Bone Graft (BMP-2) | Standard surgery plus BMP-2 | | OG001 | Control Group | Standard surgery without BMP-2 |
| |
| Secondary | Quality of Life Score - The Transfer and Basic Mobility Core Scale | Quality of Life (QOL) was measured during the study using the Pediatric Outcome Data Collection Instrument (PODCI), a validated scale developed by the American Academy of Orthopaedic Surgeons to measure outcomes in orthopedic interventions. The Parent-report form, which was used for this study, consists of 86 Likert-format questions, covering 5 domains (Upper extremity and physical function; transfer and basic mobility; sports/physical functioning; pain/comfort; and happiness scales). In addition, a Global Functioning Scale is computed. Scores for each subscale range from 0 to 100, with lower scores representing better quality of life. | The population consisted of 2 evaluable participants. Three (3) participants withdrew for various reasons (see participant flow). The study was closed for further enrollment due to poor recruitment. The study was closed after the last participant completed study procedures. | Posted | | Median | Full Range | score on a scale | | Assessed at 6 and 12 months after surgery. Month 12 reported. | | | | ID | Title | Description |
|---|
| OG000 | INFUSE Bone Graft (BMP-2) | Standard surgery plus BMP-2 | | OG001 | Control Group | Standard surgery without BMP-2 |
| |
| Secondary | Quality of Life Score - The Sports and Physical Functioning Core Scale | Quality of Life (QOL) was measured during the study using the Pediatric Outcome Data Collection Instrument (PODCI), a validated scale developed by the American Academy of Orthopaedic Surgeons to measure outcomes in orthopedic interventions. The Parent-report form, which was used for this study, consists of 86 Likert-format questions, covering 5 domains (Upper extremity and physical function; transfer and basic mobility; sports/physical functioning; pain/comfort; and happiness scales). In addition, a Global Functioning Scale is computed. Scores for each subscale range from 0 to 100, with lower scores representing better quality of life. | The population consisted of 2 evaluable participants. Three (3) participants withdrew for various reasons (see participant flow). The study was closed for further enrollment due to poor recruitment. The study was closed after the last participant completed study procedures. | Posted | | Median | Full Range | score on a scale | | Assessed at 6 and 12 months after surgery. Month 12 reported. | | | | ID | Title | Description |
|---|
| OG000 | INFUSE Bone Graft (BMP-2) | Standard surgery plus BMP-2 | | OG001 | Control Group | Standard surgery without BMP-2 |
| |
| Secondary | Quality of Life Score - The Pain/Comfort Core Scale | Quality of Life (QOL) was measured during the study using the Pediatric Outcome Data Collection Instrument (PODCI), a validated scale developed by the American Academy of Orthopaedic Surgeons to measure outcomes in orthopedic interventions. The Parent-report form, which was used for this study, consists of 86 Likert-format questions, covering 5 domains (Upper extremity and physical function; transfer and basic mobility; sports/physical functioning; pain/comfort; and happiness scales). In addition, a Global Functioning Scale is computed. Scores for each subscale range from 0 to 100, with lower scores representing better quality of life. | The population consisted of 2 evaluable participants. Three (3) participants withdrew for various reasons (see participant flow). The study was closed for further enrollment due to poor recruitment. The study was closed after the last participant completed study procedures. | Posted | | Median | Full Range | score on a scale | | Assessed at 6 and 12 months after surgery. Month 12 reported. | | | | ID | Title | Description |
|---|
| OG000 | INFUSE Bone Graft (BMP-2) | Standard surgery plus BMP-2 | | OG001 | Control Group | Standard surgery without BMP-2 |
| |
| Secondary | Quality of Life Score - The Happiness Core Scale | Quality of Life (QOL) was measured during the study using the Pediatric Outcome Data Collection Instrument (PODCI), a validated scale developed by the American Academy of Orthopaedic Surgeons to measure outcomes in orthopedic interventions. The Parent-report form, which was used for this study, consists of 86 Likert-format questions, covering 5 domains (Upper extremity and physical function; transfer and basic mobility; sports/physical functioning; pain/comfort; and happiness scales). In addition, a Global Functioning Scale is computed. Scores for each subscale range from 0 to 100, with lower scores representing better quality of life. | The population consisted of 2 evaluable participants. Three (3) participants withdrew for various reasons (see participant flow). The study was closed for further enrollment due to poor recruitment. The study was closed after the last participant completed study procedures. | Posted | | Median | Full Range | score on a scale | | Assessed at 6 and 12 months after surgery. Month 12 reported. | | | | ID | Title | Description |
|---|
| OG000 | INFUSE Bone Graft (BMP-2) | Standard surgery plus BMP-2 | | OG001 | Control Group | Standard surgery without BMP-2 |
| |
| Secondary | Quality of Life Score - The Global Functioning Scale | Quality of Life (QOL) was measured during the study using the Pediatric Outcome Data Collection Instrument (PODCI), a validated scale developed by the American Academy of Orthopaedic Surgeons to measure outcomes in orthopedic interventions. The Parent-report form, which was used for this study, consists of 86 Likert-format questions, covering 5 domains (Upper extremity and physical function; transfer and basic mobility; sports/physical functioning; pain/comfort; and happiness scales). In addition, a Global Functioning Scale is computed. Scores for each subscale range from 0 to 100, with lower scores representing better quality of life. | The population consisted of 2 evaluable participants. Three (3) participants withdrew for various reasons (see participant flow). The study was closed for further enrollment due to poor recruitment. The study was closed after the last participant completed study procedures. | Posted | | Median | Full Range | score on a scale | | Assessed at 6 and 12 months after surgery. Month 12 reported. | | | | ID | Title | Description |
|---|
| OG000 | INFUSE Bone Graft (BMP-2) | Standard surgery plus BMP-2 | | OG001 | Control Group | Standard surgery without BMP-2 |
| |